Imipramine-Induced Facial Pigmentation: Case Report and Literature Review Andrei I. MetelitsaGia-Khanh NguyenAndrew N. Lin OriginalPaper Pages: 341 - 345
Unilateral Basal Cell Carcinomas: An Unusual Entity Treated with Photodynamic Therapy Joshua E. LaneJennifer H. AllenJack L. Lesher Jr OriginalPaper 25 May 2006 Pages: 336 - 340
Multiple Cutaneous and Uterine Leiomyomas Associated with Gastric Gist Manisha LambaShailendra VermaTerence Moyana OriginalPaper 25 May 2006 Pages: 332 - 335
The Cochrane Skin Group: Promoting the Best Evidence Avanta CollierKathryn R. JohnsonHywel Williams OriginalPaper 25 May 2006 Pages: 324 - 331
Safety of Efalizumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: Review of Clinical Data. Part II Kim A. PappCharles CamisaAlice B. Gottlieb OriginalPaper 25 May 2006 Pages: 313 - 323
Clinical Efficacy of Efalizumab in Patients With Chronic Plaque Psoriasis: Results From Three Randomized Placebo-Controlled Phase III Trials: Part I David M. PariserKenneth B. GordonMark Lebwohl OriginalPaper 25 May 2006 Pages: 303 - 312
Off-Label Dermatologic Uses of Anti-TNF-a Therapies Andrew F. AlexisBruce E. Strober OriginalPaper 25 May 2006 Pages: 296 - 302
Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis Kim A. PappVincent HoCatherine Zip OriginalPaper 20 April 2006 Pages: 26 - 32
Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches Richard G. LangleyVincent HoCatherine Zip OriginalPaper 20 April 2006 Pages: 18 - 25
Molecular Aspects of Ultraviolet Radiation-induced Apoptosis in the Skin Jeffrey ChowVictor A. Tron OriginalPaper 25 May 2006 Pages: 289 - 295
A favourable benefit/risk ratio with efalizumab: A review of the clinical evidence Yves PoulinKim A. PappAditya K. Gupta OriginalPaper 20 April 2006 Pages: 10 - 17
Safe Psoriasis Control: A New Outcome Measure for the Composite Assessment of the Efficacy and Safety of Psoriasis Treatment Kim A. PappEric Henninger OriginalPaper 25 May 2006 Pages: 276 - 283
Efalizumab, a reversible T-cell modulator for psoriasis Neil H. ShearRichard G. LangleyVincent Ho OriginalPaper 20 April 2006 Pages: 4 - 9
Efalizumab: Integrating a new biologic agent into the long-term management of moderate to severe plaque psoriasis Charles Lynde OriginalPaper 20 April 2006 Pages: 1 - 3
Safety and Efficacy of a Milk-derived Extract in the Treatment of Plaque Psoriasis:An Open-label Study Y. PoulinY. PouliotS. F. Gauthier OriginalPaper 25 May 2006 Pages: 271 - 275
6. Phototherapy, Photomedicine, and Pigmentary Disorders OriginalPaper 20 April 2006 Pages: 241 - 243
Familial Bullous Lichen Planus (FBLP): Pedigree Analysis and Clinical Characteristics Changzheng HuangSiyuan ChenYouwen Zhou Basic/Clinical Science 02 March 2006 Pages: 217 - 222
Successful Treatment of Refractory Aquagenic Pruritus with Naltrexone Sarah IngberPaul D. Cohen Case Report 02 March 2006 Pages: 215 - 216
Evaluation of the Effectiveness of Imiquimod and 5-Fluorouracil for the Treatment of Actinic Keratosis: Critical Review and Meta-analysis of Efficacy Studies Aditya K. GuptaValerie DaveyHeather Mcphail Review 02 March 2006 Pages: 209 - 214
6. Phototherapy, Photomedicine, and Pigmentary Disorders OriginalPaper 20 April 2006 Pages: 190 - 192
Cytokine and Growth Factor mRNA Expression Patterns Associated with the Hypercontracted, Hyperpigmented Healing Phenotype of Red Duroc Pigs: A Model of Abnormal Human Scar Development? Corrie L. Gallant–BehmMerle E. OlsonDavid A. Hart Basic/Clinical Science 02 March 2006 Pages: 165 - 177
Successful Hair Transplant of Eyebrow Alopecia Areata Benjamin BarankinMuba TaherNorman Wasel Case Reports 02 March 2006 Pages: 162 - 164
Canadian Practical Guide for the Treatment and Management of Atopic Dermatitis Charles LyndeKirk BarberNeil Shear OriginalPaper 30 June 2005
